ARTICLE | Company News
Perthera, Novartis deal
February 10, 2017 9:46 PM UTC
Perthera will use its Precision Cancer Analysis process to identify patients that will benefit from undisclosed breast and lung cancer drugs from Novartis. Precision Cancer Analysis provides a molecul...